Latest News
If Lockdown Was a Drug, Would We Use It? On Thursday I asked why lockdowns aren't subject to the same rigorous safety and efficacy protocols as drugs and vaccines despite their huge collateral harms for questionable pay-offs. Today we're publishing an original piece by three scientific researchers that looks at exactly this question. The authors are Dr Kerry Nield, Dr Juergen Dobmeyer and Dr David Cook, who between them have over 60 years' experience in the field of drug development and clinical research. So they know what they're talking about when they say: if Lockdown was a drug, we would not use it. From the introduction: One of the central tenets of healthcare provision is that all patients have the right to expect equal treatment. Unfortunately, much as we might wish to offer the best treatments to all, there are only finite resources available and so it is necessary to balance the needs of different patients to ensure their fairest distribution. This is a difficult balancing act, but over the years we have developed approaches to ensure such judgements are as objective and as equitable as possible. In the UK, the National Institute for Health and Care Excellence (NICE) is responsible for doing this, but the approaches taken by NICE are not unique and similar methods are used by healthcare ...
